Register entry
- Registered sites
- 0
- Active NDC listings
- 2
- Live patents
- 0
- Countries
- 0
Catalogue
Drug listings by form and route
22 active NDC listings: 2 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 2.
| Dosage form | NDCs |
|---|---|
| powder | 2 |
| Route | NDCs |
|---|
| Labeller name on the listing | NDCs |
|---|---|
| labortoire schmidt-nagel inc. | 2 |
Catalogue
Marketed products
2| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| - | Allium cepa, Ambrosia artemisiifolia, Arundo mauritanica, Dulcamara, Euphrasia officinalis, Nux vomica, Pulsatilla, Ranunculus bulbosus, Sabadilla, Sinapis nigra, Sticta pulmonaria, Wyethia helenoides | powder | 73296-071DRUG FOR FURTHER PROCESSING |
| - | Cinchona officinalis, Cocculus indicus, Arnica montana, Coffea cruda, Tabacum | powder | 73296-021DRUG FOR FURTHER PROCESSING |
Compare
Other companies listing allium cepa, ambrosia artemisiifolia, arundo mauritanica, dulcamara, euphrasia officinalis, nux vomica, pulsatilla, ranunculus bulbosus, sabadilla, sinapis nigra, sticta pulmonaria, wyethia helenoides
- Genexa, Inc.0 sites · 42 NDC
Enquiry
Common questions
- Is Labortoire Schmidt-Nagel Inc. FDA approved?
- Labortoire Schmidt-Nagel Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Labortoire Schmidt-Nagel Inc. make?
- 2 products are listed under Labortoire Schmidt-Nagel Inc. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.